When the tiredness stopped feeling like ordinary tiredness — when it felt cellular, like something was running on the wrong fuel — that's when questions about mitochondria and what actually supports them started to matter. Taurine wasn't on the radar for a long time, and that feels like a gap worth closing for anyone else hitting that same wall.
Learn more about Rose →Circulating taurine levels drop significantly across the lifespan, with a measurable decline accelerating in midlife. Estrogen appears to upregulate the enzymes involved in taurine synthesis, meaning the hormonal shift of perimenopause may compound the age-related drop. A 2023 study in Science identified taurine deficiency as a driver of multiple aging hallmarks, putting this amino acid squarely in the conversation about menopause-related decline.
Taurine is required for the proper modification of mitochondrial transfer RNA, a process that keeps mitochondria producing energy efficiently. When taurine is deficient, mitochondrial protein synthesis falters and ATP output drops — which maps directly onto the kind of deep, unrelenting fatigue many women describe in perimenopause. Since estrogen itself supports mitochondrial biogenesis, its decline creates a double vulnerability that taurine may help partially offset.
Cardiovascular risk rises after menopause, and taurine has a well-documented role in regulating blood pressure, reducing arterial stiffness, and lowering LDL oxidation. A meta-analysis published in Hypertension Research found that taurine supplementation significantly reduced systolic and diastolic blood pressure in adults with prehypertension. For women navigating the cardiovascular vulnerability that comes with estrogen loss, this is one of the more evidence-supported reasons to pay attention.
Metabolic dysregulation — including rising fasting glucose and worsening insulin sensitivity — is a common and underappreciated feature of perimenopause. Taurine appears to improve insulin signalling, reduce hepatic glucose output, and protect pancreatic beta cells from oxidative stress. Several small RCTs have shown improvements in insulin sensitivity with taurine supplementation, which matters enormously given that visceral fat accumulation in this life stage is tightly linked to insulin resistance.
Taurine has agonist activity at GABA-A receptors, the same inhibitory pathway targeted by anti-anxiety medications, giving it a genuine neurological mechanism rather than just speculative calm-promoting claims. Declining estrogen destabilises GABA signalling, which is one of the physiological explanations for the anxiety and irritability that emerge in perimenopause. While human clinical trials on taurine specifically for perimenopausal anxiety are limited, the receptor-level evidence for its calming role is solid.
Because taurine modulates GABA activity and reduces cortisol-driven neuronal excitability, it may support the transition into deeper sleep stages — an area that deteriorates significantly during perimenopause. Animal studies show taurine increases sleep duration and improves sleep architecture, and its GABAergic mechanism gives this a plausible physiological basis. Human evidence is still emerging, but for women whose sleep disruption is driven partly by nervous system hyperarousal rather than hot flushes alone, this is worth noting.
Taurine is one of the most abundant free amino acids in human tissue and functions as a direct antioxidant, scavenging hypochlorous acid and buffering oxidative stress in cells under metabolic strain. Estrogen itself is a potent antioxidant in many tissues, so its withdrawal increases oxidative load — a background condition that contributes to inflammation, cognitive changes, and accelerated cellular aging. Taurine's antioxidant role doesn't replace estrogen, but it addresses some of the same downstream damage.
Taurine is essential for bile acid conjugation — the process by which the liver emulsifies dietary fat for absorption — and adequate taurine status is associated with healthier lipid profiles and reduced non-alcoholic fatty liver risk. As estrogen declines, women become more susceptible to dyslipidaemia and visceral fat accumulation, both of which place greater demand on hepatic fat processing. Taurine's role here is foundational rather than dramatic, but it contributes meaningfully to the metabolic picture.
Taurine occurs naturally in meat, fish, and shellfish, and decades of use in infant formula and sports supplements have produced a substantial safety record with no significant adverse effects at typical supplemental doses of 1–3g per day. Unlike many supplements discussed in the menopause space, taurine has no known hormonal activity, no significant drug interactions in healthy adults, and is not a stimulant despite its presence in energy drinks. Women curious about trying it are working with a compound that has a genuinely reassuring safety profile.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.